Package 55513-221-21

{"route": ["SUBCUTANEOUS"], "spl_id": "74d31919-0ed2-4e98-abd8-7cc3e011646b", "openfda": {"nui": ["N0000175969", "N0000175970", "N0000175973", "N0000175968"], "upc": ["0355513221016", "0355513222013"], "unii": ["GN5XU2DXKV"], "spl_set_id": ["c45f9a58-37c1-4f76-8e36-97d38c577037"], "pharm_class_pe": ["Increased Megakaryocyte Maturation [PE]", "Increased Platelet Production [PE]"], "pharm_class_epc": ["Thrombopoietin Receptor Agonist [EPC]"], "pharm_class_moa": ["Thrombopoietin Receptor Agonists [MoA]"], "manufacturer_name": ["Amgen, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (55513-221-01)  / .5 mL in 1 VIAL", "package_ndc": "55513-221-01", "marketing_start_date": "20080825"}, {"sample": false, "description": "1 VIAL in 1 CARTON (55513-221-21)  / .5 mL in 1 VIAL", "package_ndc": "55513-221-21", "marketing_start_date": "20250801"}], "brand_name": "Nplate", "product_id": "55513-221_74d31919-0ed2-4e98-abd8-7cc3e011646b", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Increased Megakaryocyte Maturation [PE]", "Increased Platelet Production [PE]", "Thrombopoietin Receptor Agonist [EPC]", "Thrombopoietin Receptor Agonists [MoA]"], "product_ndc": "55513-221", "generic_name": "romiplostim", "labeler_name": "Amgen, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nplate", "active_ingredients": [{"name": "ROMIPLOSTIM", "strength": "250 ug/.5mL"}], "application_number": "BLA125268", "marketing_category": "BLA", "marketing_start_date": "20080825", "listing_expiration_date": "20271231"}